Medipal Holdings Corporation TSE:7459

MediPal : Notice of Transfer of Representative Director (Additional Selection) and Acting President

Published

Source: MarketScreener

May 23, 2025 MEDIPAL HOLDINGS CORPORATION

Representative: Shuichi Watanabe, Representative Director, President and CEO Code number: 7459 (Prime Market, Tokyo Stock Exchange)

Contact: Yuji Sakon, Managing Director, General Manager of Administration Division

Tel: +81-3-3517-5171

Notice of Transfer of Representative Director (Additional Selection) and Acting President

We hereby announce that, at today's board meeting, the Board of Directors resolved to appoint an additional representative director and designated him to act on behalf of the president.

  1. Reason for transfer

    Mr. Shuichi Watanabe, Representative Director, President and CEO, has been undergoing medical treatment. As an interim measure, Mr. Yasuhiro Choufuku, Director, Vice President, was appointed as an additional representative director, creating a two-member representative director structure.

    Mr. Choufuku will act on behalf of the president.

  2. Name and title of newly appointed representative director

    Name

    New Position

    Current Position

    Yasuhiro Choufuku

    Representative Director, Vice President

    Director, Vice President

  3. Brief personal history of newly appointed representative director Name: Yasuhiro Choufuku

    Date of birth: December 8, 1954 Brief personal history:

    Apr. 1977 Joined Sanseido Co., Ltd. (now the Company)

    Jul. 2004 Executive Officer of KURAYA SANSEIDO Inc. (now the Company) Jun. 2007 Director of Mediceo Paltac Holdings Co., Ltd. (now the Company) Oct. 2009 Director of MEDICEO CORPORATION

    Jun. 2010 Managing Director of MEDICEO CORPORATION Apr. 2012 Representative Director, President and CEO of

    MEDICEO CORPORATION

    Jun. 2012 In charge of the Company's pharmaceutical business (current position) Jun. 2016 Senior Managing Director of the Company

    Jun. 2019 Director, Vice President of the Company (current position)

    Apr. 2022 Representative Director, Chairman of MEDICEO CORPORATION

    (current position)

    Mar. 2023 Outside Director, Chairman of Nichi-Iko Pharmaceutical Co., Ltd. (current position)

    Number of Company shares held: 53,800 shares

  4. Inauguration date:

May 23, 2025

# # #

The English version of this document is a translation of the Japanese original and is provided for informational purposes only. While reasonable efforts have been made to provide an accurate translation, no liability is assumed by MEDIPAL HOLDINGS CORPORATION for any errors, omissions, or ambiguities in the translation. In the event of any inconsistencies or conflicts between the English version and the Japanese original, the Japanese original shall prevail.